“…The seroprevalence was lower than that reported in other European countries including Italy 2.3% [12], the Netherlands 0.9% [13], Germany 1.7% [14], Greece 4-14% [15] and Finland 5% (range 0-12% dependent on region) [16]. However, in those studies, only IFA or enzyme immunoassay (EIA) were used to detect antibodies.…”